European Medicines Agency welcomes continuation of D:A:D study
- Details
- Category: EMA

FDA Approves Drug for Patients with Advanced Prostate Cancer
- Details
- Category: FDA

FDA's Monthly Video Series Wins Award
- Details
- Category: FDA

EMEA recommends the suspension of the marketing authorisation of Ionsys (fentanyl hydrochloride)
- Details
- Category: EMA

FDA Warns Public of Extortion Scam by FDA Impersonators
- Details
- Category: FDA

FDA Seizes Contaminated Heparin from a Cincinnati Manufacturer
- Details
- Category: FDA

FDA Issues Warning Letters to Bayer HealthCare for Illegally Marketing Two Unapproved Drugs
- Details
- Category: FDA

More Pharma News ...
- EMEA recommends suspension of the marketing authorisation of Acomplia
- European Medicines Agency recommends update of product information of Tysabri
- FDA Approves Expanded Uses for Gardasil to Include Preventing Certain Vulvar and Vaginal Cancers
- FDA Approves First Bone Marrow Stimulator to Treat Immune-Related Low Platelet Counts
- European Medicines Agency recommends restricting the use of oral moxifloxacin-containing medicines
- EMEA recommendation on use of angiotensin II receptor antagonists during pregnancy
- FDA Issues Alert on Tussionex, a Long-Acting Prescription Cough Medicine Containing Hydrocodone